Melvyn Bridges
Non-Executive Director, was Chair to 2020 / OADS
Dr Melvyn Bridges has over 35 years of experience in founding and building international life-science, diagnostic and medical device companies and commercialising a wide range of Australian technology.
Dr Bridges has been the non-executive director of Benitec, Tissue Therapies, ImpediMed; and chair of Alchemia, Genetic Technology Group and Leaf Energy.
He holds a Bachelor of Science, a Doctorate from the Queensland University of Technology, and is a Fellow of the Australian Institute of Company Directors.
